Eidy de Oliveira Santos

Dr. Eidy de Oliveira Santos

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2017 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
CLCamila Macedo da Luz
Camila Macedo da Luz
MBMatthew Samuel Powys Boyles
Matthew Samuel Powys Boyles
PFPriscila Falagan-Lotsch
Priscila Falagan-Lotsch
MPMariana Pereira
Mariana Pereira
HTHenrique Rudolf Tutumi
Henrique Rudolf Tutumi
PLPaulo Correa Leite
Paulo Correa Leite
Poly-lactic acid nanoparticles (PLA-NP) are a type of polymeric NP, frequently used as nanomedicines, which have advantages over metallic NP such as the ability to maintain therapeutic drug levels for sustained periods of time. Despite PLA-NP being considered biocompatible, data concerning alterations in cellular physiology are scarce. We conducted an extensive evaluation of PLA-NP biocompatibility in human lung epithelial A549 cells using high throughput screening and more complex methodologies. These included measurements of cytotoxicity, cell viability, immunomodulatory potential, and effects upon the cells’ proteome. We used non- and green-fluorescent PLA-NP with 63 and 66 nm diameters, respectively. Cells were exposed with concentrations of 2, 20, 100 and 200 µg/mL, for 24, 48 and 72 h, in most experiments. Moreover, possible endocytic mechanisms of internalization of PLA-NP were investigated, such as those involving caveolae, lipid rafts, macropinocytosis and clathrin-coated pits. Cell viability and proliferation were not altered in response to PLA-NP. Multiplex analysis of secreted mediators revealed a low-level reduction of IL-12p70 and vascular epidermal growth factor (VEGF) in response to PLA-NP, while all other mediators assessed were unaffected. However, changes to the cells’ proteome were observed in response to PLA-NP, and, additionally, the cellular stress marker miR155 was found to reduce. In dual exposures of staurosporine (STS) with PLA-NP, PLA-NP enhanced susceptibility to STS-induced cell death. Finally, PLA-NP were rapidly internalized in association with clathrin-coated pits, and, to a lesser extent, with lipid rafts. These data demonstrate that PLA-NP are internalized and, in general, tolerated by A549 cells, with no cytotoxicity and no secretion of pro-inflammatory mediators. However, PLA-NP exposure may induce modification of biological functions of A549 cells, which should be considered when designing drug delivery systems. Moreover, the pathways of PLA-NP internalization we detected could contribute to the improvement of selective uptake strategies.

6 September 2024 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
Gean Carlo Pereira-SilvaGean Carlo Pereira-Silva
Gean Carlo Pereira-Silva
JMJorge Mansur Medina
Jorge Mansur Medina
LPLetícia Paschoaletto
Letícia Paschoaletto
LMLuana Mangeth
Luana Mangeth
FCFelipe Soares Coelho
Felipe Soares Coelho
ESElvira Saraiva
Elvira Saraiva
Neutrophils interact with Leishmania when the sandfly vector inoculates these parasites in the host with saliva and promastigotes-derived extracellular vesicles (EVs). It has been shown that this co-injection induces inflammation and exacerbates leishmaniasis lesions. EVs are a heterogeneous group of vesicles released by cells that play a crucial role in intercellular communication. Neutrophils are among the first cells to interact with the parasites and release neutrophil extracellular traps (NETs) that ensnare and kill the promastigotes. Here, we show that Leishmania amazonensis EVs induce NET formation and identify molecular mechanisms involved. We showed the requirement of neutrophils’ toll-like receptors for EVs-induced NET. EVs carrying the virulence factors lipophosphoglycan and the zinc metalloproteases were endocytosed by some neutrophils and snared by NETs. EVs-induced NET formation required reactive oxygen species, myeloperoxidase, elastase, peptidyl arginine deiminase, and Ca++. The proteomic analysis of the EVs cargo revealed 1,189 proteins; the 100 most abundant identified comprised some known Leishmania virulent factors. Importantly, L. amazonensis EVs-induced NETs lead to the killing of promastigotes and could participate in the exacerbated inflammatory response induced by the EVs, which may play a role in the pathogenesis process.

6 April 2025 in Archives of Oral Biology
Verified
Journal Article
Closed access
CSCarlos José Ferreira da Silva
Carlos José Ferreira da Silva
Carlos Vinicius Ferreira da SilvaCarlos Vinicius Ferreira da Silva
Carlos Vinicius Ferreira da Silva
Alexander Machado CardosoAlexander Machado Cardoso
Alexander Machado Cardoso
ESEidy de Oliveira Santos
Eidy de Oliveira Santos

21 January 2026 in Archives of Microbiology
Verified
Journal Article
Open access
PDF file
JSJoão Vitor Geisteira Oliveira da Silva
João Vitor Geisteira Oliveira da Silva
ESEidy de Oliveira Santos
Eidy de Oliveira Santos
Kaposi’s sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8 (HHV-8), is an oncogenic virus responsible for Kaposi’s sarcoma (KS) and lymphoproliferative disorders like primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD). This review explores KSHV’s oncogenic mechanisms, focusing on its ability to manipulate host cell signaling, evade immune detection, and promote tumorigenesis through latent and lytic viral proteins. Key oncoproteins, such as LANA, vCyc, vFLIP, and vGPCR, activate cancer hallmarks, as sustained proliferation, immune evasion, angiogenesis, and resistance to cell death, by modulating pathways such as PI3K/AKT/mTOR and NF-κB. While histopathology and LANA staining remain diagnostic standards, emerging technologies, including advanced imaging and new molecular biomarkers, assay improved early detection. Of KSHV current therapies face challenges, especially in immunocompromised patients, highlighting the need for targeted treatments addressing viral infection. Next-generation approaches, such as CRISPR-Cas9 and therapeutic aptamers, aim to inhibit viral replication, modulate oncogenic pathways, and enhance immune responses. Current diagnosis of KS still relies primarily on histopathology and LANA immunostaining, which remain the gold standard but present important limitations, particularly in early or atypical lesions and in distinguishing latent from lytic infection. Despite advances in conventional chemotherapy and antiretroviral therapy, KSHV-associated malignancies lack virus-specific targeted treatments, and clinical outcomes remain suboptimal, especially in immunocompromised patients. By integrating emerging diagnostic biomarkers, such as viral microRNAs, with next-generation therapeutic strategies—including gene editing and synthetic biology-based approaches—this review highlights opportunities for precision medicine to improve disease detection, therapeutic specificity, and patient outcomes. Collectively, we provide a comprehensive framework for understanding KSHV-driven oncogenesis while outlining critical directions for future diagnostic and therapeutic innovation.

20 September 2025 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
DSda Silva
da Silva
JOJoão Vitor Geisteira Oliveira
João Vitor Geisteira Oliveira
JVJessica Manya Bittencourt Dias Vieira
Jessica Manya Bittencourt Dias Vieira
ESEidy de Oliveira Santos
Eidy de Oliveira Santos

1 November 2025 in Current Probiotics
Verified
Journal Article
Closed access
PDF file
CBCristiana Guimarães Brasileiro
Cristiana Guimarães Brasileiro
MMMarcos Thalyson da Conceição Moreno
Marcos Thalyson da Conceição Moreno
ESEidy de Oliveira Santos
Eidy de Oliveira Santos
PSPazhani Saranraj
Pazhani Saranraj
Alexander Machado CardosoAlexander Machado Cardoso
Alexander Machado Cardoso
JVJessica Manya Bittencourt Dias Vieira
Jessica Manya Bittencourt Dias Vieira
Probiotics have become a tool for individuals seeking a better quality of life, through a healthier and more balanced lifestyle, whether by engaging in physical activities or adopting socalled "natural" diets. Of course, amidst numerous superficial and potentially harmful diets, some stand out for fulfilling their role in enhancing the well-being of those who follow them, even if they do not deliver the miraculous results promised by others. One such practice is consuming probiotic foods, which are rich in microorganisms capable of providing benefits to the host. These microorganisms can traverse the entire digestive tract and, upon reaching the intestines, colonize this region. Therefore, this review aims to present some of the probiotics used in these diets: Rejuvelac, kefir, sauerkraut, kombucha and kimchi. It is interesting to compare these fermented foods' production techniques, microbiota composition, and bioactive components. Despite their differences, they share key microbial genera that play crucial roles in fermentation and health-promoting properties.